Press Releases

Date Title and Summary View
Toggle Summary Horizon Technology Finance Announces Fourth Quarter and Full Year 2014 Financial Results
Improves Credit Quality; Portfolio Yield Exceeds 15% Record Number of Portfolio Liquidity Events for the Year FARMINGTON, Conn. , March 10, 2015 (GLOBE NEWSWIRE) -- Horizon Technology Finance Corporation (Nasdaq:HRZN) (the "Company" or "Horizon"), a leading specialty finance company that provides...
View HTML
Toggle Summary Horizon Technology Finance to Announce Fourth Quarter and Full Year 2014 Financial Results
FARMINGTON, Conn. , Feb. 24, 2015 (GLOBE NEWSWIRE) -- Horizon Technology Finance Corporation (Nasdaq:HRZN) (the "Company" or "Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...
View HTML
Toggle Summary VC-backed Inotek Pharmaceuticals unveils IPO - PE Hub
VC-backed Inotek Pharmaceuticals unveils IPO https://www.pehub.com/2015/02/vc-backed-inotek-pharmaceuticals-unveils-ipo/...
View HTML
Toggle Summary Horizon commits $7.5M to Mass. optical imager - Hartford Business
Horizon commits $7.5M to Mass. optical imager http://www.hartfordbusiness.com/article/20150210/NEWS01/150219994...
View HTML
Toggle Summary Horizon Technology Finance Leads $15 Million Venture Loan Facility for NinePoint Medical
FARMINGTON, CT and CAMBRIDGE, MA / ACCESSWIRE / February 9, 2015 / Horizon Technology Finance Corporation ("Horizon") (NASDAQ: HRZN), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...
View HTML
Toggle Summary Horizon Technology Finance Provides Investment Portfolio Update for Fourth Quarter 2014
<ul><li>Active Origination and Portfolio Liquidity Events Drive Positive Momentum; Strong Liquidity to Grow Portfolio in 2015</il></ul> ...
View HTML
Toggle Summary Horizon Technology Finance Provides $5 Million Venture Loan to Interleukin Genetics
FARMINGTON, CT and WALTHAM, MA / ACCESSWIRE / December 30, 2014 / Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare...
View HTML
Toggle Summary Horizon Technology Finance Leads $10 Million Venture Loan for Palatin Technologies
FARMINGTON, CT and CRANBURY, NJ / ACCESSWIRE / December 29, 2014 / Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...
View HTML
Toggle Summary Horizon's $15M bioscience buy in - Hartford Business
Horizon's $15M bioscience buy in http://www.hartfordbusiness.com/article/20141229/NEWS01/141229962...
View HTML
Toggle Summary Interleukin Genetics snags $10 mln - PE Hub
Interleukin Genetics snags $10 mln https://www.pehub.com/2014/12/interleukin-genetics-snags-10-mln/...
View HTML
Contact

Horizon Technology Finance
Dan Trolio
Executive Vice President & CFO
(860) 674-9977
dtrolio@horizontechfinance.com

ICR Group
Garrett Edson
Managing Director
(646) 200-8885
ir@horizontechfinance.com

Horizon Technology Finance
312 Farmington Avenue
Farmington, CT
06032

Jerry Michaud
(860) 676-8659
jmichaud@horizontechfinance.com

Horizon Technology Finance
349 Main Street
Suite 203
Pleasanton, CA
94566

Kevin May
(925) 935-2924
kmay@horizontechfinance.com
Nasdaq SBIA NYSE
HORIZON TECHNOLOGY FINANCE
A Life Sciences & Technology Venture Lending Partner

info@horizontechfinance.com | Privacy Policy | Site Map

Loans made or arranged in California pursuant to a California Financing Law license.

Copyright © 2024 Horizon Technology Finance Management LLC. All rights reserved.

website by DIANA STUTZ DESIGN